巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Simulations Plus

    SLP
    48.750
    2.180
    4.68%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Simulations Plus - 延遲價格・最後更新於 27/05 8:00
    最高位
    48.760
    最低位
    46.820
    開市價
    --
    前收市價
    46.570
    成交量(千)
    6.45
    成交額(百萬)
    2.82
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    985.07
    市盈率
    87.050
    息率
    0.50%
    差價
    --
    52週高低
    57.960 - 35.178
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Simulations Plus
    證券代碼
    SLP.US
    所屬板塊
    Health Information Services
    公司業務
    Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Simulations Plus, Inc; Cognigen Corporation; DILIsym, and Lixoft. It generates maximum revenue from Simulations Plus, Inc segment. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Predictor which is a computer program that takes molecular structures as inputs; MedChem Designer and MedChem Studio.
    發行量
    20147714
    公司總部
    42505 Tenth Street West
    公司網址
    https://www.simulations-plus.com
    公司電郵
    renee@simulations-plus.com
    公司電話
    +1 661 723-7723
    暫無內容

    關於

    Simulations Plus(SLP.US)所屬的行業板塊為Health Information Services。
    Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Simulations Plus, Inc; Cognigen Corporation; DILIsym, and Lixoft. It generates maximum revenue from Simulations Plus, Inc segment. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Predictor which is a computer program that takes molecular structures as inputs; MedChem Designer and MedChem Studio.
    截至27/05 08:00:05,Simulations Plus的股價升4.68,市值985.07百萬。Simulations Plus的市盈率及息率分別為87.050及0.50%。
    詳細公司背景可參考: https://www.simulations-plus.com